Skip to content
The GLP-1 Verdict
Menu
Ranked #227 · Grade C

Found review

An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.

Pricing last checked on Found's own site .

Visit Found Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly
Tirzepatide
From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly
Coverage
Most states (exact exclusion list not published)
Brand-name
Yes

The scorecard

Found scored on our six published factors. See the methodology.

Real-world results68/100
Price honesty45/100
Prescriber access70/100
Formulary choice88/100
Cancellation fairness55/100
Member support65/100

What we like

  • Genuinely broad formulary: compounded semaglutide and tirzepatide, four brand GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound) and the oral pill Foundayo (orforglipron), plus non-GLP-1 options like Contrave and metformin
  • Real insurance brokering, not just a marketing claim — partners with Blue Cross, United Healthcare, Aetna, Cigna and Anthem, and most members reportedly pay under $30/visit
  • A new Medicare GLP-1 Bridge program gets eligible Part D members brand Wegovy, Zepbound or Foundayo for a flat $50/mo copay
  • Publishes molecule-specific outcome data with a methodology footnote (16% average loss on GLP-1 injections; 12.1% in 6 months on tirzepatide for treatment-naive members) rather than one generic number

The caveats

  • The advertised $99/mo is a floor that requires insurance approval AND a 12-month prepaid commitment — without both, the real price is $169–$289/mo, up to 2.9x the headline
  • Both molecules are priced as one undifferentiated "GLP-1 program" fee rather than a per-drug figure
  • Brand-name self-pay is materially more expensive: Ozempic and Mounjaro run roughly $1,100/mo, Wegovy and Zepbound from $650/mo+
  • The $50/mo Medicare copay is a named, time-limited bridge program (through December 2027), not a standing price
  • No specific list of excluded states is published, only a generic disclaimer that coverage varies by state
  • Compounded semaglutide and tirzepatide are not FDA-approved

The verdict

Best for: Insured patients willing to prepay a year up front, or Medicare Part D members eligible for the time-limited $50/mo brand-name bridge program. An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.

Ranked #227 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Fierce Health at #226, 68/100 above and System Labs at #228, 65/100 below, with the Belle Health ruling the next one down.

Weighing it against something else? Every provider we would put in front of Found is ranked on price honesty, prescriber access and cancellation terms.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Found goes to CoreAge Rx, 94/100 to 65/100.

Compare with other providers

The closest rulings to Found by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect Found's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.

← Back to all rankings